Chris Polman, Free University of Amsterdam
Abstract N Engl J Med 2006;345:899
Despite fears that natalizumab – which reduces progression in some categories of patients with multiple sclerosis – might increased the risk of a fatal viral infection, two-year randomised study finding have now given some reassurance that patients with relapsing disease can be treated.
[audio:https://www.audiomedica.com/podcasting/news/chris_polman.mp3]
A middle cerebral artery anueurism: International Subarachnoid Aneurism Trial (ISAT) 27 Sep, 2005 Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen 2 Aug, 2007 GnRH Antagonist Protects Ovarian Function During Chemotherapy 2 Aug, 2007 Audio Journal of Hematologic Malignancy Special Edition 2005 14 Jan, 2006 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014